Evidence map›Paper›PMID 41055583›Full record

ArticleStatistics in medicine2025

A Practical Framework to Design Immunization Studies Based on the Beta Distribution.

Stefan Embacher, Andrea Berghold, Kirsten Maertens, Sereina A Herzog

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stefan EmbacherInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Andrea BergholdInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0001-5187-9105
Kirsten MaertensCentre for the Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Sereina A HerzogInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.

Funding

Austrian Science Fund I 6376-BFonds Wetenschappelijk Onderzoek G004723N
6 · The paper itself

Abstract

An optimally designed experiment reaches results quicker, at a lower cost, or with fewer observations and is therefore crucial in maximizing resource efficiency in research. In immunization studies, the primary goal is often to characterize antibody kinetics-the change in antibody concentration over time. However, nonlinear models for antibody kinetics present substantial challenges for study design, particularly the need to provide information on the parameters of interest. We propose a novel framework to facilitate the design of immunization studies using simple, understandable information. We assume that the mean antibody concentration follows the structural form of the beta density until reaching a plateau. Using the time and height of the maximum and the time and height of the plateau, we can uniquely determine the antibody kinetics curve. Optimal sampling schedules are determined using D-optimality, with D-efficiency used to compare designs. In a robustness analysis across 12 scenarios, we analyzed the framework's sensitivity to misspecification in the initial information. When misspecifying one parameter at a time, the median D-efficiencies exceeded 0.95 and the first quartiles were greater than or equal to 0.9 for all parameters, highlighting the robustness of the framework. Misspecification in the height of the plateau and time of the maximum affected the D-efficiency the most. The great advantage of the framework is that we only need intuitive information from the medical professionals to design an immunization study, in which determining the antibody kinetics is the main goal.

Indexed as

ImmunizationModels, StatisticalResearch DesignAntibodiesComputer SimulationHumansKineticsNonlinear DynamicsAntibodiesantibody kineticsimmunization studyoptimal sampling schedulestudy design

Identifiers

PMID41055583
PMCPMC12503089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.